Research on Metformin pharmacogenomics in the treatment of type 2 diabetes / 中国糖尿病杂志
Chinese Journal of Diabetes
;
(12): 760-764, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-612154
ABSTRACT
Metformin is a first-line therapy for type 2 diabetes mellitus.Individual variation in response to metformin exists in clinical practice,which is associated with genetic background.Current researches focus on elucidating the relationship between the polymorphisms of genes and the absorption,transportation,metabolism,and excretion of metformin,and also pharmacogenomics of metformin treatment.Pharmacogenomics also provides theoretical basis for individualized therapy.Here,we reviewed the literature progress for metformin pharmacogenomics.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Diabetes
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS